Participated in Proton Intelligence's $6.95M seed round for continuous potassium monitoring in kidney disease patients.
Proton Intelligence is developing CKM™, an investigational wearable platform designed to turn potassium visibility into actionable insight for clinicians managing cardio-kidney disease
Proton Intelligence is developing CKM™, an investigational wearable platform designed to turn potassium visibility into actionable insight for clinicians managing cardio-kidney disease.